⌘K

Login Start Free

Home/Filings/4/0000899243-22-000130

4//SEC Filing

Humer Kristian 4

Accession 0000899243-22-000130

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:16 PM ET

Size

5.8 KB

Accession

0000899243-22-000130

Insider Transaction Report

Form 4

Period: 2021-12-31

Viridian Therapeutics, Inc.\DEVRDN

CFO and CBO

Transactions

Award
Stock Option (Right to Buy)
2021-12-31+121,371→ 121,371 total
Exercise: $19.77Exp: 2031-12-31→ Common Stock (121,371 underlying)

Footnotes (1)

[F1]The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001872280

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:16 PM ET
Size: 5.8 KB

View on SEC.gov